Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Health Affairs (Project Hope)
|
September 16, 2005
Vaccine risk and benefit in the developing world
Jerald C Sadoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2010
Update on research and development pipeline: tuberculosis vaccines
Belinda Beresford, Jerald C Sadoff
Microbes and Infection
|
May 10, 2005
The role of "go no-go" decisions in TB vaccine development
Jerald C Sadoff, David Hone
The Journal of Infectious Diseases
|
October 9, 2007
Correlates, surrogates, and vaccines
Jerald C Sadoff, Janet Wittes
Nature Reviews. Microbiology
|
May 20, 2006
Advances in tuberculosis vaccine strategies
Yasir A W Skeiky, Jerald C Sadoff
BMC Medical Genomics
|
May 29, 2008
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses
Anat Zvi, Naomi Ariel, John Fulkerson, et al.
Current Opinion in Immunology
|
June 10, 2009
Tuberculosis vaccine research: the impact of immunology
Lewellys F Barker, Michael J Brennan, Peri K Rosenstein, et al.
European Journal of Immunology
|
September 21, 2011
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
Richard Hopkins, Anne Bridgeman, Charles Bourne, et al.
Journal of Virology
|
May 21, 2010
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques
Maximillian Rosario, John Fulkerson, Shamit Soneji, et al.
The Journal of Infectious Diseases
|
September 24, 2008
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers
Daniel F Hoft, Azra Blazevic, Getahun Abate, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Health Affairs (Project Hope)
|
September 16, 2005
Vaccine risk and benefit in the developing world
Jerald C Sadoff
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2010
Update on research and development pipeline: tuberculosis vaccines
Belinda Beresford, Jerald C Sadoff
Microbes and Infection
|
May 10, 2005
The role of "go no-go" decisions in TB vaccine development
Jerald C Sadoff, David Hone
The Journal of Infectious Diseases
|
October 9, 2007
Correlates, surrogates, and vaccines
Jerald C Sadoff, Janet Wittes
Nature Reviews. Microbiology
|
May 20, 2006
Advances in tuberculosis vaccine strategies
Yasir A W Skeiky, Jerald C Sadoff
BMC Medical Genomics
|
May 29, 2008
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses
Anat Zvi, Naomi Ariel, John Fulkerson, et al.
Current Opinion in Immunology
|
June 10, 2009
Tuberculosis vaccine research: the impact of immunology
Lewellys F Barker, Michael J Brennan, Peri K Rosenstein, et al.
European Journal of Immunology
|
September 21, 2011
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
Richard Hopkins, Anne Bridgeman, Charles Bourne, et al.
Journal of Virology
|
May 21, 2010
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques
Maximillian Rosario, John Fulkerson, Shamit Soneji, et al.
The Journal of Infectious Diseases
|
September 24, 2008
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers
Daniel F Hoft, Azra Blazevic, Getahun Abate, et al.
Page
of 3